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Prevention of recurrent stroke in adults with patent foramen ovale repre- 
sents a therapeutic challenge. Antiplatelet or anticoagulant treatment is
widely introduced, but its exact indication is not known. In this pilot study, 
eight men and three women with previous ischemic cerebral events 
underwent direct surgical closure of the patent foramen ovale. Mean age 
was 39.4 (from 30 to 58) years. No coexisting cause of stroke was found after 
extensive investigations, including blood and coagulation tests, echocardi- 
ography, 24-hour three-lead electrocardiographic monitoring, extracranial 
and transcranial Doppler ultrasonography, and cerebral angiography. 
Criteria for operation also included at least two of the following: atrial 
septal aneurysm, multiple cerebral infarcts, a history of multiple cerebral 
events, and Valsalva strain before stroke. Before operation, one patient had 
two shunts (1 patent foramen ovale, 1 intrapulmonary shunt). No intraop- 
erative or postoperative complications occurred, but a few hours after 
operation transient arrhythmias developed in two patients without atrial 
fibrillation, hemodynamic instability, or embolism. During a median 
follow-up of 12.2 months, no patient had recurrent stroke. All patients 
prospectively underwent brain magnetic resonance imaging and contrast 
echocardiography with simultaneous transcranial Doppler ultrasonogra- 
phy. A residual right-to-left interatrial shunt, smaller than the preoperative 
one, was observed in only one patient, whereas no lesion was seen on 
magnetic resonance imaging. Our study suggests that surgical closure of 
patent foramen ovale in patients with presumed paradoxic embolism is 
safe, with no recurrent stroke in the first year of follow-up. Further studies 
are needed to evaluate the long-term prognosis of patients with versus 
without operation and to define the role of operation as an alternative to 
prolonged antithrombotic treatment. (J Thorac Cardiovasc Surg 1996;112: 
260-3) 
A high prevalence of patent foramen ovale (PFO) 
in patients with cryptogenic ischemic cerebral 
infarct has been defined. >3 In these cases, paradoxic 
embolism is the presumed mechanism, although it is 
rarely proved. Moreover, the magnitude of the risk 
of paradoxic embolism in the presence of PFO has 
not been determined. In patients with PFO, recur- 
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rent stroke cannot be completely prevented by anti- 
platelet therapy, anticoagulation therapy, or transcath- 
eter closure. < 5 Concerning the latter procedure, more 
than 10% of patients had recurrent transient ischemic 
attack in a recent study. 6 In the present study we 
assessed irect surgical closure of PFO and report 
the perioperative morbidity and the intermediate 
follow-up, 
Patients and methods 
Patients. Between December 1992 and October 1994, 
11 patients (8 men, 73%) with PFO and previous stroke, 
from 30 to 58 years old (average age, 39.4 years), were 
selected for direct surgical closure of PFO. Stroke was 
defined as an acute, permanent neurologic deficit with a 
corresponding lesion in a recognized arterial distribution 
identified by magnetic resonance imaging (MRI) or com- 
puted tomography or as an acute focal transient neuro- 
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logic deficit wit]bout a corresponding lesion on MRI or 
computed tomography. All subjects were selected on the 
basis of the protocol reported in Table I, after informed 
consent was obtained from each patient, respecting the 
Helsinky principles. Seven patients had at least one of the 
following thromboembolic r sk factors: cigarette smoking 
(3 patients), hypercholesterolemia (3 patients), obesity (1 
patient), and heredity (2 patients). Preoperative trans- 
esophageal contrast echocardiography (TEE) with Val- 
salva maneuver showed positive findings for right-to-left 
atrial shunting in all patients. Atrial septal aneurysm was 
demonstrated in three cases, as well as an intrapulmonary 
shunt in one case, which could not be localized. The 
criteria used for diagnosis of atrial septal aneurysm in- 
cluded a base width of greater than 1.5 cm and an 
excursion beyond the plane of atrial septum of at least 10 
mm. 7 PFO was defined as a natural interatrial channel, 
which did not close after birth because pressure in the left 
atrium exceeded that in the right atrium. The maximal size 
of the orifice reached 16 mm, in accordance with the 
values reported in previous studies. 8 One patient had 
chronic bronchial asthma, treated with terbutaline sulfate. 
Operation. All patients underwent the operation via a 
median sternotomy. Cardiopulmonary b pass (CPB) was 
instituted with cannulation of the ascending aorta and 
both venae cavae. Mild hypothermia was achieved, and 
myocardial protection ensured by infusion of 600 ml 
hypothermic crystalloid solution into the aortic root and 
by topical epicardial cooling. The PFO was identified 
through a right atriotomy. In 10 patients, the PFO was 
sutured, posterior to the tendon of Todaro, with contin- 
uous 4-0 polypropylene suture. Separate stitches were 
placed in one case. In the patients with atrial septal 
aneurysm, atrial septal plication was done with the same 
continuous uture. The atrial incision was closed with 4-0 
polypropylene suture and, after deairing, the aortic cross- 
clamp was removed. CPB was discontinued after the 
patient was warmed to higher than 35 ° C rectal tempera- 
ture. Before protamine administration, contrast TEE was 
done, excluding a residual shunt in all patients. The 
sternal incision 'was closed in the usual manner. 
Postoperative follow-up. Chest roentgenography, elec- 
trocardiography, and echocardiography were repeated 
before hospital discharge. Within a median period of 12.2 
months (from 4 to 24.3 months) all patients were seen 
clinically and underwent ambulatory transcranial Doppler 
ultrasonography combined with TEE and Valsalva ma- 
neuver, which was realized after injection of 10 ml isotonic 
saline solution containing air microbubbles into a periph- 
eral vein. Chest roentgenography and electrocardiography 
were also done. Brain MRI was done to detect silent 
infarcts that might have occurred uring follow-up. 
Results 
The median time between the initial neurologic 
event and surgical closure of the PFO was 1.4 
months (range 7 days to 89 days). Procedures were 
done by six surgeons and operative time was 100 to 
165 minutes (median, 145 minutes). Crossclamp and 
CPB median times were, respectively, 16 minutes 
Table I. Patient selection criteria 
N 
PFO assessed by contrast TEE 11 
Stroke of unknown origin* 11 
At least 2 of following: 
Atrial septal aneurysm 3 
Multiple cerebral infarcts 7 
Multiple cerebral events 9 
Valsalva strain before stroke 3 
Age <59 yr 11 
*No evidence ofembolic source at extracranial and transcraniaI Doppler 
ultrasonography, MRI, computed tomography, blood and coagulation 
tests, TEE, and 24-hour electrocardiographic monitoring. 
(range 10 to 24 minutes) and 30 minutes (range 25 
to 42 minutes). Sinus rhythm reappeared spontane- 
ously in nine patients and after a 10 joule internal 
electric shock in two. Transient arrhythmias devel- 
oped in two patients a few hours after the operation 
(1 nodal rhythm and 1 ventricular tachycardia, 
which reverted immediately to sinus rhythm after 
intravenous lidocaine bolus). No atrial fibrillation, 
hemodynamic instability, or embolic events were 
seen. Six patients received renal doses of dopamine 
(0.5 /xg/kg per minute) in the first 12 to 24 hours. 
Patients left the intensive care unit after a median 
stay of 19.6 hours (range 8 to 24 hours). Only one 
patient needed a 600 ml autologous blood transfu- 
sion. Total chest drainage ranged from 265 to 670 ml 
(median, 457 ml). Chest tubes were removed within 
31 to 48 hours (median, 44 hours). Recovery was 
uneventful in all patients. In particular, there was no 
pericardial or pleural effusion, no residual intracar- 
diac shunt, no atrioventricular block and no stroke 
during the 10.5-day median hospital stay (range 8 to 
12 days). One patient, known to have psychotic 
episodes, had behavioral disturbances 2 months 
after the operation, without evidence of simulta- 
neous thromboembolic events. At 12.2 months no 
stroke or extracranial embolic event had occurred in 
any patient, and brain MRI  showed no new visible 
lesion. The patient who had PFO closure with 
separated stitches has the only residual right-to-left 
interatrial shunt at the Valsalva maneuver (15 mi- 
crobubbles); the preoperative shunt had been larger 
(>20 bubbles). Although a residual interatrial shunt 
was excluded by TEE in the patient with intrapul- 
monary shunt, transcranial Doppler ultrasonogra- 
phy showed late massive contrast passage (>20 
microbubbles), consistent with this extracardiac 
shunt. In three patients with correction of atrial 
septal aneurysm, there was no residual bulging of 
the interatrial septum. Electrocardiograms and 
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chest x-ray films showed normal findings in all 
patients. 
Discussion 
A PFO prevalence of 40% has been reported in 
young adults with cryptogenic stroke, 1 but it has 
been shown that PFO is a risk factor for thrombo- 
embolic events in all age groups. 9 We therefore 
decided to include older patients (up to 59 years) in 
our study. However, the tight criteria of our selec- 
tion protocol enabled us to exclude patients with 
another potential cause of stroke. Although this has 
not been demonstrated in a controlled study, we 
selected patients for operation who had multiple 
brain events, a history of Valsalva strain, or atrial 
septal aneurysm because these factors may be asso- 
ciated with higher isk of stroke recurrence than the 
risk in other patients with stroke and PFO. 1°' 1~ 
Currently, the most common treatment toreduce 
the frequency of recurrent paradoxic emboli s an- 
ticoagulation, but prognosis in patients who receive 
long-term anticoagulation with thromboembolic 
transient ischemic attacks or stroke is compromised 
by hemorrhagic complications, mainly cerebral. 1a-14 
Buttoned evices constitute another therapeutic al- 
ternative, but often must be associated with antico- 
agulation, especially when stroke recurs. 6' 15 Surgical 
therapy has the potential of obviating the need for 
an intracardiac prosthesis and for anticoagulation 
with its attendant problems of patient compliance 
and also of excluding recurrent paradoxic embolism. 
In our series, the only residual shunt was probably a
result of a separated stitches technique, which sug- 
gests that continuous uture distributes harmoni- 
ously the tension on the tissues, decreasing the risk 
of local rupture. We therefore decided to close PFO 
systematically with continuous suture. Air embolism 
is the most serious threat to patients undergoing 
PFO or atrial septal defect closure and this may be 
avoided by minimizing intraoperative aspiration of 
the atrial blood and aspiration of air from the aortic 
root before electric ardioversion. The few reported 
deaths have been associated with massive air embo- 
lism or perioperative cardiac failure in elderly pa- 
tientsJ 6 Although no deaths occurred in our series 
and morbidity was minimal, we believe that a pro- 
spective randomized trial should be undertaken to 
evaluate the long-term efficacy of surgical versus 
medical or interventional approach. The duration of 
hospitalization was quite long compared with cur- 
rent standards. However, this allowed for careful 
follow-up. Patients underwent TEE between post- 
operative days 7 and 10, when the endothelialization 
process hould have been achieved. 
Recurrence of stroke after surgical PFO closure 
may not be linked to paradoxic embolism, but to 
another cause of stroke. Indeed, in patients with 
recurrent stroke without residual interatrial shunt or 
atrial septal aneurysm, a stroke mechanism other 
than paradoxic embolism must be considered. Fur- 
thermore, considering the prevalence of PFO in the 
general population (up to 35%) and the rather low 
risk of recurrence in patients with PFO and 
stroke, it, 13, 17 it is necessary to identify persons at 
particularly high risk for paradoxic embolism and 
stroke recurrence in future studies. Encouraged by 
the results presented in this paper, we successfully 
performed surgical PFO closure in 11 additional 
patients, selected according to the protocol noted 
herein, who were discharged from the hospital in 
good clinical condition. 
In our experience, surgical therapy for PFO clo- 
sure in selected patients was safe and no recurrent 
stroke occurred uring follow-up. We suggest that 
selection criteria used in this pilot study be used in 
future randomized trials comparing medical and 
surgical options. 
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